NCT00116415 - DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

HIV InfectionsAIDS

Interventions

DRUG

efavirenz; didanosine EC; lamivudine

Trial Locations (9)

Local Institution, Washington D.C.

Local Institution, Orlando

Local Institution, Columbus

Local Institution, Boston

Local Institution, Springfield

Local Institution, Kansas City

Local Institution, Hillsborough

Local Institution, The Bronx

Local Institution, Dallas